This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
In preparation for EBW2019 taking place in Lübeck October 7th- 11th, 2019, ESBB and BBMRI-ERIC are honoured and proud to have Prof. Olli Kallioniemi, M.D., Ph.D. as EBW2019 keynote speaker! Prof. Kallioniemi is Director of Science for Life Laboratory (www.SciLifeLab.se), a national infrastructure for life sciences in Sweden and professor in Molecular Precision Medicine at the Karolinska Institutet. He was previously the founding director of FIMM – the Institute for Molecular Medicine Finland at the University of Helsinki, as part of the Nordic EMBL partnership in Molecular Medicine (with ongoing adjunct affiliation). Prof. Kallioniemi has a broad experience in launching and leading research organizations, promoting careers of young scientists, working with research infrastructures and attractive research environments. He has collaborated broadly within the Nordics, in the EU and globally. Prof. Kallioniemi received his M.D. in 1984, Ph.D. in 1988 and specialty training in laboratory medicine at the University of Tampere in Finland. He undertook a postdoc at UC San Francisco 1990-1992 and was nominated as faculty at the National Human
Genome Research Institute (1995-2001). Prof. Kallioniemi’s research group is currently active in individualized systems medicine of cancer, with a focus on improving the diagnostics and therapy of leukemia, prostate and ovarian cancer. Prof. Kallioniemi has facilitated launch of grand challenge initiatives in personalized medicine in Finland and Sweden, involving close collaborations with hospitals, health care organizations and industry. We are looking forward to Prof. Kallioniemi’s keynote lecture with highest interest!